| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J9271 |
Injection, pembrolizumab, 1 mg |
5,533 |
4,121 |
$58.87M |
| J9035 |
Injection, bevacizumab, 10 mg |
4,120 |
2,214 |
$18.95M |
| J9299 |
Injection, nivolumab, 1 mg |
1,620 |
1,055 |
$14.58M |
| J9306 |
Injection, pertuzumab, 1 mg |
2,374 |
1,678 |
$14.10M |
| J9355 |
Injection, trastuzumab, excludes biosimilar, 10 mg |
2,003 |
1,393 |
$9.40M |
| J0897 |
Injection, denosumab, 1 mg |
3,102 |
2,545 |
$8.30M |
| J9358 |
Injection, fam-trastuzumab deruxtecan-nxki, 1 mg |
715 |
465 |
$7.29M |
| J9312 |
Injection, rituximab, 10 mg |
1,159 |
653 |
$6.22M |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
2,380 |
1,704 |
$5.68M |
| J9022 |
Injection, atezolizumab, 10 mg |
540 |
401 |
$5.35M |
| Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg |
1,565 |
768 |
$4.62M |
| J9042 |
Injection, brentuximab vedotin, 1 mg |
107 |
88 |
$4.04M |
| J9145 |
Injection, daratumumab, 10 mg |
528 |
270 |
$3.85M |
| Q5117 |
Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg |
1,477 |
803 |
$3.59M |
| J9055 |
Injection, cetuximab, 10 mg |
446 |
271 |
$3.50M |
| J9354 |
Injection, ado-trastuzumab emtansine, 1 mg |
520 |
282 |
$3.49M |
| J2353 |
Injection, octreotide, depot form for intramuscular injection, 1 mg |
473 |
368 |
$2.43M |
| J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg |
780 |
484 |
$2.41M |
| J9264 |
Injection, paclitaxel protein-bound particles, 1 mg |
221 |
184 |
$1.51M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
1,437 |
1,325 |
$1.30M |
| J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj |
94 |
83 |
$1.26M |
| J9317 |
Injection, sacituzumab govitecan-hziy, 2.5 mg |
76 |
53 |
$1.04M |
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
146 |
129 |
$966K |
| J9047 |
Injection, carfilzomib, 1 mg |
97 |
41 |
$795K |
| J0490 |
Injection, belimumab, 10 mg |
238 |
152 |
$794K |
| J9070 |
Cyclophosphamide, 100 mg |
1,711 |
1,004 |
$517K |
| J9395 |
Injection, fulvestrant, 25 mg |
1,019 |
831 |
$442K |
| J9202 |
Goserelin acetate implant, per 3.6 mg |
599 |
453 |
$428K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
2,459 |
2,095 |
$360K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
4,774 |
2,477 |
$318K |
| J7312 |
Injection, dexamethasone, intravitreal implant, 0.1 mg |
177 |
142 |
$300K |
| J9171 |
Injection, docetaxel, 1 mg |
2,294 |
1,136 |
$269K |
| J9305 |
Injection, pemetrexed, not otherwise specified, 10 mg |
140 |
74 |
$250K |
| J9075 |
Injection, cyclophosphamide, not otherwise specified, 5 mg |
666 |
328 |
$192K |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
3,123 |
1,556 |
$182K |
| Q5115 |
Injection, rituximab-abbs, biosimilar, (truxima), 10 mg |
75 |
36 |
$151K |
| J3489 |
Injection, zoledronic acid, 1 mg |
2,312 |
2,001 |
$136K |
| J1453 |
Injection, fosaprepitant, 1 mg |
1,238 |
941 |
$130K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
67 |
53 |
$121K |
| Q5119 |
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg |
54 |
26 |
$119K |
| J9267 |
Injection, paclitaxel, 1 mg |
3,074 |
1,611 |
$115K |
| J9190 |
Injection, fluorouracil, 500 mg |
4,139 |
2,327 |
$102K |
| J9206 |
Injection, irinotecan, 20 mg |
1,912 |
853 |
$92K |
| J9049 |
Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg |
474 |
348 |
$90K |
| J9045 |
Injection, carboplatin, 50 mg |
3,162 |
1,738 |
$84K |
| J9000 |
Injection, doxorubicin hydrochloride, 10 mg |
2,188 |
1,237 |
$51K |
| J9201 |
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg |
712 |
427 |
$44K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13,662 |
10,296 |
$40K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,716 |
6,578 |
$31K |
| J9060 |
Injection, cisplatin, powder or solution, 10 mg |
632 |
433 |
$27K |
| J9044 |
Injection, bortezomib, not otherwise specified, 0.1 mg |
13 |
13 |
$25K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
10,216 |
7,696 |
$21K |
| J9181 |
Injection, etoposide, 10 mg |
66 |
53 |
$3K |
| J9370 |
Vincristine sulfate, 1 mg |
187 |
140 |
$3K |
| J1750 |
Injection, iron dextran, 50 mg |
13 |
13 |
$2K |
| S0028 |
Injection, famotidine, 20 mg |
1,917 |
1,534 |
$2K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
207 |
125 |
$2K |
| J9130 |
Dacarbazine, 100 mg |
24 |
12 |
$725.39 |
| J3490 |
Unclassified drugs |
1,149 |
824 |
$625.50 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
182 |
139 |
$490.76 |